Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Anpac Bio-Medical Science CO ADR (ANPC)

Anpac Bio-Medical Science CO ADR (ANPC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,842
  • Shares Outstanding, K 15,319
  • Annual Sales, $ 3,140 K
  • Annual Income, $ -12,330 K
  • 60-Month Beta 1.90
  • Price/Sales 16.62
  • Price/Cash Flow N/A
  • Price/Book 31.41
Trade ANPC with:

Options Overview

Details
  • Implied Volatility 130.32%
  • Historical Volatility 60.47%
  • IV Percentile 63%
  • IV Rank 46.78%
  • IV High 219.03% on 07/27/21
  • IV Low 52.35% on 08/30/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 26
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 4

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.30 +8.48%
on 08/20/21
3.83 -6.41%
on 09/09/21
-0.10 (-2.72%)
since 08/17/21
3-Month
3.30 +8.48%
on 08/20/21
5.60 -36.07%
on 06/18/21
-0.75 (-17.32%)
since 06/17/21
52-Week
3.15 +13.65%
on 10/05/20
12.09 -70.39%
on 03/09/21
-1.62 (-31.09%)
since 09/17/20

Most Recent Stories

More News
AnPac Bio's USA Laboratory Receives Accreditation from the College of American Pathologists

AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that its Philadelphia, PA...

ANPC : 3.58 (+4.99%)
AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration (NMPA) for Registration Testing of Its Multi-Cancer CDA Device

via Investor Wire - AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announces that...

ANPC : 3.58 (+4.99%)
AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO

via InvestorWire -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announces that...

ANPC : 3.58 (+4.99%)
AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions

AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that Announced that AnPac...

ANPC : 3.58 (+4.99%)
AnPac Bio Announces Appointment of New Independent Director

AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that Mr. Chao Feng, who...

ANPC : 3.58 (+4.99%)
AnPac Bio Began Generating Contract Medical Device R&D Revenue

AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection,...

ANPC : 3.58 (+4.99%)
AnPac Bio Pre-announces that During First Half 2021, Total Commercial Testing Volume Increased Approximately 110% Over the Same Period 2020 and Q2 Paid Cancer Tests Increased Approximately 270% Over Q1

AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection...

ANPC : 3.58 (+4.99%)
Thinking about buying stock in AMC Entertainment, AnPac Bio-Medical Science, General Electric, JPMorgan, or Cyclo Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, ANPC, GE, JPM, and CYTH.

AC : 35.12 (-2.01%)
ANPC : 3.58 (+4.99%)
CYTH : 6.81 (+3.03%)
AMC : 44.20 (-4.00%)
GE : 100.47 (-0.86%)
JMP : 7.48 (unch)
GEC.LN : 101.380 (unch)
AnPac Bio's First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds

AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection...

ANPC : 3.58 (+4.99%)
AnPac Bio Reports Strong First Quarter in 2021, with 137.2% Increase in Revenue and Record Number of Commercial Tests Completed

AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial...

ANPC : 3.58 (+4.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AnPac Bio-Medical Science Co., Ltd. is a biotechnology company focused on early cancer screening and detection. AnPac Bio-Medical Science Co., Ltd. is based in China.

See More

Key Turning Points

3rd Resistance Point 4.23
2nd Resistance Point 3.99
1st Resistance Point 3.79
Last Price 3.58
1st Support Level 3.35
2nd Support Level 3.11
3rd Support Level 2.91

See More

52-Week High 12.09
Fibonacci 61.8% 8.67
Fibonacci 50% 7.62
Fibonacci 38.2% 6.57
Last Price 3.58
52-Week Low 3.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar